FR2145402A1 - Magnesium acetylglycinate hexahydrate - for treating hypomagnesaemia - Google Patents
Magnesium acetylglycinate hexahydrate - for treating hypomagnesaemiaInfo
- Publication number
- FR2145402A1 FR2145402A1 FR7125666A FR7125666A FR2145402A1 FR 2145402 A1 FR2145402 A1 FR 2145402A1 FR 7125666 A FR7125666 A FR 7125666A FR 7125666 A FR7125666 A FR 7125666A FR 2145402 A1 FR2145402 A1 FR 2145402A1
- Authority
- FR
- France
- Prior art keywords
- magnesium
- acetylglycinate
- hypomagnesaemia
- hexahydrate
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010021027 Hypomagnesaemia Diseases 0.000 title abstract 2
- UDUBOGXZIMAWHZ-UHFFFAOYSA-L magnesium 2-acetamidoacetate hexahydrate Chemical compound O.O.O.O.O.O.C(C)(=O)NCC(=O)[O-].[Mg+2].C(C)(=O)NCC(=O)[O-] UDUBOGXZIMAWHZ-UHFFFAOYSA-L 0.000 title abstract 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 abstract 4
- 229910001629 magnesium chloride Inorganic materials 0.000 abstract 2
- 241000283973 Oryctolagus cuniculus Species 0.000 abstract 1
- 230000036765 blood level Effects 0.000 abstract 1
- 230000007012 clinical effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- KGUYBGVVODEWIJ-UHFFFAOYSA-L magnesium 2,4-dioxo-1H-pyrimidine-6-carboxylate 2-hydroxypropanoate Chemical compound C(C(O)C)(=O)[O-].C(C1=CC(=O)NC(=O)N1)(=O)[O-].[Mg+2] KGUYBGVVODEWIJ-UHFFFAOYSA-L 0.000 abstract 1
- 239000001095 magnesium carbonate Substances 0.000 abstract 1
- 235000014380 magnesium carbonate Nutrition 0.000 abstract 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 abstract 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 abstract 1
- OVGXLJDWSLQDRT-UHFFFAOYSA-L magnesium lactate Chemical compound [Mg+2].CC(O)C([O-])=O.CC(O)C([O-])=O OVGXLJDWSLQDRT-UHFFFAOYSA-L 0.000 abstract 1
- 229960004658 magnesium lactate Drugs 0.000 abstract 1
- 235000015229 magnesium lactate Nutrition 0.000 abstract 1
- 239000000626 magnesium lactate Substances 0.000 abstract 1
- 238000006386 neutralization reaction Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7125666A FR2145402A1 (en) | 1971-07-13 | 1971-07-13 | Magnesium acetylglycinate hexahydrate - for treating hypomagnesaemia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7125666A FR2145402A1 (en) | 1971-07-13 | 1971-07-13 | Magnesium acetylglycinate hexahydrate - for treating hypomagnesaemia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2145402A1 true FR2145402A1 (en) | 1973-02-23 |
| FR2145402B1 FR2145402B1 (enExample) | 1974-09-06 |
Family
ID=9080306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7125666A Granted FR2145402A1 (en) | 1971-07-13 | 1971-07-13 | Magnesium acetylglycinate hexahydrate - for treating hypomagnesaemia |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2145402A1 (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4196196A (en) * | 1978-06-19 | 1980-04-01 | Tiholiz Ivan C | Divalen/monovalent bipolar cation therapy for enhancement of tissue perfusion and reperfusion in disease states |
| EP0130644A1 (en) * | 1983-06-30 | 1985-01-09 | Continental Pharma, Inc. | Use of 2-Pentanoylaminoacetic acid and salts thereof |
-
1971
- 1971-07-13 FR FR7125666A patent/FR2145402A1/fr active Granted
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4196196A (en) * | 1978-06-19 | 1980-04-01 | Tiholiz Ivan C | Divalen/monovalent bipolar cation therapy for enhancement of tissue perfusion and reperfusion in disease states |
| EP0130644A1 (en) * | 1983-06-30 | 1985-01-09 | Continental Pharma, Inc. | Use of 2-Pentanoylaminoacetic acid and salts thereof |
| US4562205A (en) * | 1983-06-30 | 1985-12-31 | Continental Pharma Inc. | Derivatives of 2-aminoacetic acid |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2145402B1 (enExample) | 1974-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL76119A0 (en) | Initiating reperfusion treatment when heart attack symptoms are present | |
| TR17169A (tr) | Tuey muamelesi veya nubuk cilt muamelesine mahsus usul | |
| ZA72423B (en) | Improvements in or relating to the treatment of diseases of the skin or mucosa | |
| ES407058A1 (es) | Procedimiento de preparacion de un producto aromatizante. | |
| ES404616A1 (es) | Procedimiento para la obtencion de una composicion con ac- tividad anti-seborreica y de uso externo. | |
| ZA71586B (en) | Treatment of brine | |
| CH535588A (de) | Gerät zur ärztlichen Behandlung von Gelenken, Muskeln, des Nervensystems oder anderen Teilen von Lebewesen | |
| Curtis et al. | The extinction of homosexual behaviour by covert sensitization: A case study. | |
| GB1299797A (en) | Method of treating diatomaceous earth and perlite | |
| CA955067A (en) | Treatment of chloride solutions containing mixed metal chlorides | |
| AU3317971A (en) | The use of diphenylsulfones inthe treatment of mareks disease | |
| Price | The Relief of Acute Pleuritic Pain by Intercostal Nerve Block | |
| ZA711301B (en) | Treatment of titanium dioxide | |
| IT958058B (it) | Procedimento per la polimerizzazio ne in emulsione di vinil cloruro e di altri monomeri vinilici e pro dotto ottenuto | |
| BE772342A (fr) | Sels du sulfate de chondroitine, leurs procedes de preparation ainsi que leur utilisation therapeutique | |
| GB1300694A (en) | Biocidal composition and disinfecting method | |
| FR2126134A1 (en) | Cyclophosphamide/magnesium compsns - with enhanced cytostatic activity | |
| SU563438A1 (ru) | Состав дл обработки кожи | |
| FR2168924A2 (en) | Hetacephalexin compsns - for human and veterinary antibacterial therapy, and as foodstuff additive | |
| FR2390964A1 (fr) | Associations medicamenteuses comprenant de la prostacycline ou de la dihydroprostacycline | |
| SU482448A1 (ru) | Способ получени гем-дихлор-1,2диарилазиридинов | |
| GB1106430A (en) | Improvements in or relating to coagulation of latex | |
| ZA714757B (en) | Treatment of ferrous chloride liquor | |
| SU422810A1 (enExample) | ||
| FR2196792A1 (en) | L-Ornithine salt of N-acetyl-DL-methionine - useful for treating ammonae-mia or as liver-protectant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |